31
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

      The New England journal of medicine
      Massachusetts Medical Society

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Clinical trials have established the efficacy of ranibizumab for the treatment of neovascular age-related macular degeneration (AMD). In addition, bevacizumab is used off-label to treat AMD, despite the absence of similar supporting data.

          Related collections

          Author and article information

          Journal
          21526923
          3157322
          10.1056/NEJMoa1102673

          Comments

          Comment on this article

          scite_